Literature DB >> 20831301

Managed care pharmacy sees potential of comparative effectiveness research to improve patient care and lower costs.

Judith Cahill1, Neal Learner.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20831301     DOI： 10.2165/11535610-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  1 in total

1.  Impact of asthma controller medications on clinical, economic, and patient-reported outcomes.

Authors:  Hiangkiat Tan; Chaitanya Sarawate; Joseph Singer; Kurt Elward; Rubin I Cohen; Brian A Smart; Michael F Busk; James Lustig; Jeana D O'Brien; Michael Schatz
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616
  1 in total
  3 in total

1.  Perspectives on comparative effectiveness research: views from diverse constituencies.

Authors:  Dave Nellesen; Howard G Birnbaum; Paul E Greenberg
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 2.  Modelling the cost effectiveness of disease-modifying treatments for multiple sclerosis: issues to consider.

Authors:  Joel P Thompson; Amir Abdolahi; Katia Noyes
Journal:  Pharmacoeconomics       Date:  2013-06       Impact factor: 4.981

3.  Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer.

Authors:  Szu-Chun Yang; Chien-Chung Lin; Wu-Wei Lai; Sheng-Mao Chang; Jing-Shiang Hwang; Wu-Chou Su; Jung-Der Wang
Journal:  Ther Adv Med Oncol       Date:  2018-02-05       Impact factor: 8.168
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.